Monday, September 19, 2016

NCCN has announced a national "Patient Advocacy Summit" entitled "Value Tools for Patients in Cancer Care." The workshop, to be held at the National Press Club on December 9, 2016, has free registration. A flyer for the meeting is here.

NCCN previously held a summit on "Value, Access, Cost of Cancer Care" in New York on September 11, 2015 - here.

Value frameworks are plentiful - from ICER in Boston; from Sloan-Kettering (Drug Abacus, here), from ASCO, and elsewhere. See the ASCO Value Framework here. See also the organization and trade journal, Association for Value Based Cancer Care, here. For an article in The Oncologist, May 2016, see here. For an article at AJMC, here; for a review at the ZS pharma consultancy, here; for an article in Nature Reviews Drug Discovery, here. For an article by Jason Shafrin, here.

On September 15, Washington lawmakers introduced a bill "that would require drug makers to justify their pricing and provide a breakdown of their costs before raising prices...more than 10%;" here, here, here.

Addendum - November 16, 2016

Two other December 2016 Washington workshops of interest to oncology.

On December 12-13, 2016, the Institute of Medicine holds a workshop on "Drug Development Paradigm in Oncology." Here.

On December 13-14, 2016, IOM holds a workshop on "Ensuring Patient Access to Affordable Drug Therapies." Here. A prior session on this topic was held in November 2016; here. A post meeting report by Pink Sheet (subscription), here.

In November 2016, IOM released a 9 page brief on pain and opioid harms; here.

About the Author

Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.